PLUS1
Telix Pharmaceuticals Financial Data
| Company name: | Telix Pharmaceuticals Ltd | Status: | Active |
| End of fiscal year: | 31 December 2018 | ISIN | AU000000TLX2 |
| Year established: | 2017 | Company sector name: | Healthcare |
| Trading currency: | AUD | Industry name: | Biotechnology |
| Place of incorporation: | Australia (AU) | Industry group name | Biotechnology |
| Doing business in: | Australia (AU) | Address | 55 Flemington Road Suite 401, North Melbourne, 3051 |
| Tel.: | +61 449148448 | City/Country: | Melbourne, Australia |
| Web address: | http://www.telixpharma.com |
| Company description: | Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan. |
| Price | Price change [%] | Bid | Offer | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 3.97 | -0.11[-2.7%] | 3.92 | 4.05 | 4.08 | 4.08 | 3.92 | 641,047 |
| Market Cap. [m] | Shares In Issue [m] | Beta | EPS | DPS | PE Ratio | Yield | 52-Wks-Range |
| 824.66544264 | 218.365836 | - | -0.07 | - | -59.65 | - | 1.05 - 4.80 |
TLX KEY FIGURES (at previous day's close) | |
|---|---|
Yesterday's Close | 4.08 |
PE Ratio | -59.65 |
Market Capitalisation | 824.67M |
Latest Shares Outstanding | 218.37M |
Earnings pS (EPS) | -0.07 |
Dividend pS (DPS) | - |
Dividend Yield | - |
Sales per Employee | - |
Effective Tax Rate | - |
Foreign Sales | - |
Domestic Sales | - |
Selling, General & Adm/tive (SG... | 4,651.88% |
Research & Devlopment (R&D) as ... | 0.00% |
Gross Profit Margin | 100.00% |
EBITDA Margin | - |
Pre-Tax Profit Margin | - |
Assets Turnover | - |
Return on Assets (ROA) | -0.22% |
Return on Equity (ROE) | -0.27% |
Return on Capital Invested (ROC... | -0.27% |
Current Ratio | 4.35 |
Leverage Ratio (Assets/Equity) | 1.45% |
Interest Cover | -540.52 |
Total Debt/Equity (Gearing Rati... | 0.03% |
LT Debt/Total Capital | 0.01% |
Working Capital pS | 0.34 |
Cash pS | 0.13 |
Book-Value pS | 0.18 |
Tangible Book-Value pS | 0.01 |
Cash Flow pS | - |
Free Cash Flow pS | -0.10 |
Spread | 0.13 |
Gross gearing | 0.00% |
Net Debt | -25.77M |
TLX Balance Sheet Chart (30 December 2018) | ||
|---|---|---|
 | ||
| Period † | High | Low |
|---|---|---|
| 1 Week | 4.29 | 3.92 |
| 1 Month | 4.80 | 3.92 |
| 3 Months | 4.80 | 3.47 |
| 6 Months | 4.80 | 1.605 |
| 1 Year | 4.80 | 1.05 |
| 3 Years | 4.80 | 0.54 |
| 5 Years | 4.80 | 0.00 |
Share price performance previous 3 years |
|---|
Share price performance intraday |
|---|
| Period † | Open | Open Avg. | VWAP | Min Vol | Max Vol | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|---|
| 1 Week | 4.21 | 4.128 | 4.13 | 225,881 | 694,458 | 429,349 | -0.24 | -5.7% |
| 1 Month | 4.29 | 4.3469 | 4.40 | 197,792 | 1,573,668 | 618,976 | -0.32 | -7.46% |
| 3 Months | 4.41 | 4.1522 | 4.17 | 197,792 | 1,573,668 | 611,707 | -0.44 | -9.98% |
| 6 Months | 1.79 | 3.6195 | 3.62 | 70,975 | 3,709,453 | 719,666 | 2.18 | 121.79% |
| 1 Year | 1.17 | 2.4933 | 2.45 | 58,656 | 3,997,158 | 743,612 | 2.80 | 239.32% |
| 3 Years | 0.63 | 1.5961 | 1.83 | 1,601 | 3,997,158 | 588,113 | 3.34 | 530.16% |
| 5 Years | 0.81 | 1.4687 | 1.76 | 1,601 | 3,997,158 | 543,933 | 3.16 | 390.12% |
TLX Growth Ratios (30 December 2018) | ||||
|---|---|---|---|---|
| 1 year | 3 years | 5 years | 10 years | |
Diluted EPS growth | - | - | - | - |
Diluted continuous EPS growth | - | - | - | - |
Dividend growth | - | - | - | - |
Equity per share growth | -0.03 | - | - | - |
Revenue growth | - | - | - | - |
Operating income growth | - | - | - | - |
Net income growth | - | - | - | - |
Net income cont growth | - | - | - | - |
CFO growth | - | - | - | - |
FCF growth | - | - | - | - |
Operating revenue growth | - | - | - | - |
TLX Income Statement 30 December 2018 (AUD) | |
|---|---|
Total Revenue | 0.195142 |
Operating Revenue | 0.195142 |
Gross Profit | 0.195142 |
Operating Expenses | 27.842136 |
Selling,General and Administr... | 9.077781 |
General and Administrative Ex... | 8.499835 |
Salary and Benefit | 4.897099 |
Rent and Landing Fees | 0.477902 |
OtherGandA | 3.124834 |
Selling and Marketing Expense | 0.577946 |
Research and Development | 18.692034 |
Other Operating Expenses | 0.072321 |
Operating Income | -27.646994 |
Interest Income/Expense,Net-N... | 0.303733 |
Interest Income-Non Operating | 0.332751 |
Interest Expense-Non Operatin... | 0.029018 |
Other Income/Expense,Net | 11.629368 |
Other Non-Operating Income/Ex... | 11.629368 |
Pretax Income | -15.713893 |
Provision for Income Tax | -1.884068 |
Net Income Available to Commo... | -13.829825 |
Net Income | -13.829825 |
Net Income Including Noncontr... | -13.829825 |
Net Income from Continuing Op... | -13.829825 |
Basic EPS | -0.07 |
Basic EPS from Continuing Ope... | -0.07 |
Basic EPS from Discontinued O... | 0.00 |
Diluted EPS | -0.07 |
Diluted EPS from Continuing O... | -0.07 |
Diluted EPS from Discontinued... | 0.00 |
Basic Weighted Average Shares... | 202.123883 |
Diluted Weighted Average Shar... | 202.123883 |
Net Income from Continuing an... | -13.829825 |
Normalized Income | -13.829825 |
Basic EPS,Continuing and Disc... | -0.07 |
Diluted EPS,Continuing and Di... | -0.07 |
Interest and Dividend Income | 0.332751 |
Interest Expense | 0.029018 |
Net Interest Income | 0.303733 |
Earning Before Interest and T... | -15.684875 |
Earning Before Interest Tax D... | -15.684875 |
Net Income from Continuing Op... | -13.829825 |
Normalized Basic EPS | -0.07 |
Normalized Diluted EPS | -0.07 |
NormalizedEBITDA | -15.684875 |
Tax rate for calculations | 0.12 |
TLX Efficency Ratios (30 December 2018) | |
|---|---|
Days in sales | 1,091.22 |
Days in inventory | - |
Days in payment | - |
Cash conversion cycle | - |
Receivable turnover | 0.33 |
Inventory turnover | - |
Payable turnover | - |
Fixed assets turnover | 1.69 |
Assets turnover | 0.00 |
ROE | -0.27 |
ROA | -0.22 |
ROIC | -0.27 |
FCF sales ratio | - |
FCF net income ratio | - |
Capital expenditure sales ratio | - |
TLX Financial Health Ratios (30 December 2018) | |
|---|---|
Current ratio | 4.35 |
Quick ratio | 4.15 |
Debt total capital ratio | 0.01 |
Debt equity ratio | 0.01 |
Financial leverage | 1.45 |
Total debt to equity | 0.03 |
TLX Avearge Growth Ratios Over 5 Years (30 December 2018) | |
|---|---|
Growth ann capital spending | - |
Growth ann gross profit | - |
Avg gross margin | - |
Avg post tax margin | - |
Avg pre tax marginr | - |
Avg net profit | - |
Avg ret commonr | - |
Avg ret assets | - |
Avg ret invested capital | - |
TLX Profitability Ratios (30 December 2018) | |
|---|---|
Gross margin | 1.00 |
Operating margin | -141.68 |
EBT margin | -80.53 |
Tax rate | - |
Net margin | -70.87 |
Sales per employee | - |
EBIT margin | -80.38 |
EBITDA margin | -80.38 |
Normalized net profit margin | -70.87 |
Interest coverage | -540.52 |
Inc per employee tot ops | - |
TLX Valuation Ratios (31 December 2018) | |
|---|---|
Sales per share | - |
Growth ann sales per share 5 ye... | - |
Book value per share | 0.20 |
CF per share | -0.05 |
Price to EPS | - |
Ratio PE 5 year high | - |
Ratio PE 5 year low | - |
Price to book | 3.20 |
Price to sales | - |
Price to cash flow | - |
Price to free cash flow | - |
Div rate | - |
Dividend yield | - |
Div payout tot ops | - |
Div payout 5 year | - |
Payout ratio | 0.00 |
Sustainable growth rate | - |
Cash return | -0.06 |
TLX Balance Sheet 30 December 2018 (AUD) | |
|---|---|
Total Assets | 76.708057 |
Current Assets | 35.856394 |
Cash,Cash Equivalents,and Sho... | 25.771055 |
Cash and Cash Equivalents | 25.771055 |
Cash | 25.771055 |
Receivables | 8.435847 |
Accounts Receivable | 0.677983 |
Other Receivables | 7.757864 |
Inventories | 0.642525 |
Raw Materials | 0.07961 |
Work-in-Process | 0.509534 |
Finished Goods | 0.053381 |
Prepaid Assets and Others | 0.472305 |
Other Current Assets | 0.534662 |
Total Non-Current Assets | 40.851663 |
Net Property,Plant,and Equipm... | 0.226171 |
Gross Property,Plant,and Equi... | 0.226171 |
Machinery,Furniture/Equipment | 0.226171 |
Goodwill and Other Intangible... | 39.450761 |
Goodwill | 3.14006 |
Other Intangible Assets | 36.310701 |
Accounts Receivable,Non-Curre... | 1.174731 |
Total Liabilities | 23.803647 |
Current Liabilities | 8.241701 |
Payables and Accrued Expenses | 6.89304 |
Payables | 6.89304 |
Accounts Payable | 3.248628 |
Other Payable | 3.644412 |
Pension and Other Post-Retire... | 0.215723 |
Current Debt and Capital Leas... | 1.132938 |
Current Debt | 1.132938 |
Other Current Borrowings | 1.132938 |
Total Non-Current Liabilities | 15.561946 |
Long Term Debt and Capital Le... | 0.596295 |
Long Term Debt | 0.596295 |
Deferred Liabilities, Non cur... | 4.373766 |
Deferred Taxes,Non-Current Li... | 4.373766 |
Other Non-Current Liabilities | 10.591885 |
Total Equity | 52.90441 |
Stockholder's Equity | 52.90441 |
Capital Stock | 72.052656 |
Common Stock | 72.052656 |
Retained Earnings | -20.20694 |
Accumulated Gains/ Losses Not... | 1.058694 |
Foreign Currency Translation ... | 0.053858 |
Other Equity Adjustments | 1.004836 |
Total Capitalization | 53.500705 |
Common Stock Equity | 52.90441 |
Net Tangible Assets | 13.453649 |
Working Capital | 27.614693 |
Invested Capital | 54.633643 |
Tangible Book Value | 13.453649 |
Total Debt | 1.729233 |
Ordinary Shares Number | 218.365836 |
TotalLiabilitiesAsReported | 23.803647 |
TotalEquityAsReported | 52.90441 |
TLX Cash Flow 30 December 2018 (AUD) | |
|---|---|
Classes of Cash Receipts from... | 1.17772 |
Other Cash Receipts from Oper... | 1.17772 |
Classes of Cash Payments | -22.24248 |
Payments to Suppliers for Goo... | -22.24248 |
Interest Paid, Direct | -0.017113 |
Interest Received, Direct | 0.332733 |
Cash Flow from Investing Acti... | -2.693125 |
Cash Flow from Continuing Inv... | -2.693125 |
Purchase/Sale of Business,Net | -2.693125 |
Purchase/Acquisition of Busin... | -2.693125 |
Cash Flow from Financing Acti... | -0.869354 |
Cash Flow from Continuing Fin... | -0.869354 |
Issuance/Payments of Debt,Net | -0.869354 |
Issuance/Payments of Long Ter... | -0.869354 |
Payments to Settle Long Term ... | -0.869354 |
Cash and Cash Equivalents,End... | 25.771055 |
Change in Cash | -24.311619 |
Effect of Exchange Rate Chang... | 1.32224 |
Cash and Cash Equivalents,Beg... | 48.758958 |
OtherCashAdjustExcludeFromCha... | 1,476.00 |
Interest Paid, Supplemental D... | 0.017113 |
Repayment of Debt | -0.869354 |
Free Cash Flow | -20.74914 |
ChangeinCashSupplementalAsRep... | -24.311619 |
